JP2015147762A5 - - Google Patents

Download PDF

Info

Publication number
JP2015147762A5
JP2015147762A5 JP2015002271A JP2015002271A JP2015147762A5 JP 2015147762 A5 JP2015147762 A5 JP 2015147762A5 JP 2015002271 A JP2015002271 A JP 2015002271A JP 2015002271 A JP2015002271 A JP 2015002271A JP 2015147762 A5 JP2015147762 A5 JP 2015147762A5
Authority
JP
Japan
Prior art keywords
salt
pyridin
castor oil
pharmaceutical composition
ylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015002271A
Other languages
English (en)
Japanese (ja)
Other versions
JP6012775B2 (ja
JP2015147762A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015002271A priority Critical patent/JP6012775B2/ja
Priority claimed from JP2015002271A external-priority patent/JP6012775B2/ja
Publication of JP2015147762A publication Critical patent/JP2015147762A/ja
Publication of JP2015147762A5 publication Critical patent/JP2015147762A5/ja
Application granted granted Critical
Publication of JP6012775B2 publication Critical patent/JP6012775B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015002271A 2014-01-10 2015-01-08 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 Active JP6012775B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015002271A JP6012775B2 (ja) 2014-01-10 2015-01-08 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014002809 2014-01-10
JP2014002809 2014-01-10
JP2015002271A JP6012775B2 (ja) 2014-01-10 2015-01-08 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016181739A Division JP6449205B2 (ja) 2014-01-10 2016-09-16 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物

Publications (3)

Publication Number Publication Date
JP2015147762A JP2015147762A (ja) 2015-08-20
JP2015147762A5 true JP2015147762A5 (cg-RX-API-DMAC7.html) 2016-09-23
JP6012775B2 JP6012775B2 (ja) 2016-10-25

Family

ID=53523959

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015002271A Active JP6012775B2 (ja) 2014-01-10 2015-01-08 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2016181739A Active JP6449205B2 (ja) 2014-01-10 2016-09-16 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2018227964A Active JP6793172B2 (ja) 2014-01-10 2018-12-05 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2020186245A Active JP7170020B2 (ja) 2014-01-10 2020-11-09 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2022174719A Active JP7546027B2 (ja) 2014-01-10 2022-10-31 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2016181739A Active JP6449205B2 (ja) 2014-01-10 2016-09-16 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2018227964A Active JP6793172B2 (ja) 2014-01-10 2018-12-05 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2020186245A Active JP7170020B2 (ja) 2014-01-10 2020-11-09 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2022174719A Active JP7546027B2 (ja) 2014-01-10 2022-10-31 ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物

Country Status (19)

Country Link
US (3) US20160317512A1 (cg-RX-API-DMAC7.html)
EP (2) EP3093021B1 (cg-RX-API-DMAC7.html)
JP (5) JP6012775B2 (cg-RX-API-DMAC7.html)
KR (6) KR102111157B1 (cg-RX-API-DMAC7.html)
CN (2) CN110251516B (cg-RX-API-DMAC7.html)
AU (1) AU2015205268B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016015911B1 (cg-RX-API-DMAC7.html)
CA (1) CA2934612C (cg-RX-API-DMAC7.html)
EA (1) EA031723B1 (cg-RX-API-DMAC7.html)
ES (2) ES2953346T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20186916B (cg-RX-API-DMAC7.html)
IL (1) IL246654B (cg-RX-API-DMAC7.html)
MX (1) MX2016009058A (cg-RX-API-DMAC7.html)
MY (1) MY166210A (cg-RX-API-DMAC7.html)
PH (1) PH12016501327A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201605532YA (cg-RX-API-DMAC7.html)
TW (1) TWI612960B (cg-RX-API-DMAC7.html)
UA (1) UA121744C2 (cg-RX-API-DMAC7.html)
WO (1) WO2015105134A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102111157B1 (ko) * 2014-01-10 2020-05-14 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
MX385505B (es) 2014-01-10 2025-03-18 Santen Pharmaceutical Co Ltd Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico
KR101824829B1 (ko) 2014-01-10 2018-02-01 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물을 포함하는 의약 제제
TWI794140B (zh) 2015-07-09 2023-03-01 日商參天製藥股份有限公司 含有吡啶基胺基乙酸化合物之預防及/或治療劑
EP3639854B1 (en) 2017-06-16 2026-01-07 The Doshisha Mtor-inhibitor-containing medicine for treating or preventing fuchs' endothelial corneal dystrophy
WO2018230713A1 (ja) 2017-06-16 2018-12-20 学校法人同志社 カスパーゼ阻害活性を有する化合物、これらの化合物を含む、角膜内皮の症状、障害または疾患を治療または予防するための医薬およびその応用
EP3689349A4 (en) * 2017-09-29 2021-06-23 Santen Pharmaceutical Co., Ltd. MEDICINAL PRODUCT CONTAINING A COMPOUND OF PYRIDYLAMINOACETIC ACID
KR20200103041A (ko) 2017-12-21 2020-09-01 산텐 세이야꾸 가부시키가이샤 오미데네팍의 조합
US11666563B2 (en) * 2017-12-28 2023-06-06 Santen Pharmaceutical Co., Ltd. Pharmaceutical preparation containing pyridyl aminoacetic acid compound
CN114761022B (zh) * 2019-11-29 2024-02-13 千寿制药株式会社 药物组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
EP0938896A1 (en) 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
CA2295512C (en) * 1998-07-14 2009-05-26 Alcon Laboratories, Inc. Prostaglandin product
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
US20020009507A1 (en) * 2000-01-19 2002-01-24 Alcon Universal Ltd. Use of polyethoxylated castor oil for the treatment of dry eye
JP2002356420A (ja) * 2001-03-27 2002-12-13 Santen Pharmaceut Co Ltd 安定な水性液剤
JP5460996B2 (ja) 2007-10-19 2014-04-02 大正製薬株式会社 眼科用剤
HRP20190509T1 (hr) * 2008-03-12 2019-05-03 Ube Industries, Ltd. Spoj piridilaminooctene kiseline
PT2415763E (pt) 2009-03-30 2016-03-30 Ube Industries Composição farmacêutica para tratamento ou prevenção do glaucoma
JP2011057633A (ja) * 2009-09-11 2011-03-24 Ube Industries Ltd ピリジルアミノ酢酸化合物を含有する医薬
US20120058983A1 (en) * 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
TW201309343A (zh) 2011-02-10 2013-03-01 參天製藥股份有限公司 經改善親水性藥物之藥物移行性之水性組成物
CN103596572A (zh) 2011-04-12 2014-02-19 株式会社·R-技术上野 水性眼用组合物
TW201340960A (zh) 2012-02-27 2013-10-16 Rohto Pharma 眼科用組成物套組
MY169816A (en) 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
CN104428911B (zh) 2012-07-09 2018-08-24 夏普株式会社 发光装置以及照明装置
US9339496B2 (en) * 2012-07-13 2016-05-17 Santen Pharmaceutical Co., Ltd. Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist
JP2014019650A (ja) * 2012-07-13 2014-02-03 Santen Pharmaceut Co Ltd スルホンアミド化合物とタフルプロストの組み合わせ
US20140018350A1 (en) * 2012-07-13 2014-01-16 Asahi Glass Co., Ltd. Combination of sulfonamide compound and tafluprost
KR102074020B1 (ko) 2012-07-13 2020-02-05 산텐 세이야꾸 가부시키가이샤 술폰아미드 화합물의 조합
KR102111157B1 (ko) 2014-01-10 2020-05-14 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물
MX385505B (es) 2014-01-10 2025-03-18 Santen Pharmaceutical Co Ltd Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico
KR101824829B1 (ko) * 2014-01-10 2018-02-01 산텐 세이야꾸 가부시키가이샤 피리딜아미노아세트산 화합물을 포함하는 의약 제제
EP3689349A4 (en) 2017-09-29 2021-06-23 Santen Pharmaceutical Co., Ltd. MEDICINAL PRODUCT CONTAINING A COMPOUND OF PYRIDYLAMINOACETIC ACID

Similar Documents

Publication Publication Date Title
JP2013067635A5 (cg-RX-API-DMAC7.html)
JP6012775B2 (ja) ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物
JP2016027060A5 (cg-RX-API-DMAC7.html)
HRP20210459T1 (hr) Supstituirani derivati oksopiridina
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2013542261A5 (cg-RX-API-DMAC7.html)
CN115315427A (zh) Hpk1抑制剂及其制备方法和用途
JP2015007136A5 (cg-RX-API-DMAC7.html)
AU2015205188A1 (en) Pharmaceutical preparation containing pyridylamino acetic acid compound
JP2016503058A5 (cg-RX-API-DMAC7.html)
JP2019104727A5 (cg-RX-API-DMAC7.html)
JP2015503579A5 (cg-RX-API-DMAC7.html)
WO2015105135A1 (ja) ピリジルアミノ酢酸化合物含有医薬組成物
JP2019142974A5 (cg-RX-API-DMAC7.html)
CN109689652A (zh) 稠杂环类衍生物、其制备方法及其在医学上的应用
MY191261A (en) Novel preparation containing benzimidazole derivative
JP2013518051A5 (cg-RX-API-DMAC7.html)
JP2019515040A5 (cg-RX-API-DMAC7.html)
CN113905735A (zh) 神经激肽-1拮抗剂
MX342397B (es) Uso de fluido viscoelastico para producir un producto medicinal para tratar quirurgicamente el ojo.
CN113906017A (zh) 作为rock蛋白激酶抑制剂的异喹啉酮的衍生物及其应用
CN106714806A (zh) 水性组合物
TW201542241A (zh) 兩性離子性軟式隱形眼鏡用眼科用組成物
JP2014508170A5 (cg-RX-API-DMAC7.html)
JP2013227300A5 (cg-RX-API-DMAC7.html)